CAS: 274693-27-5 - (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

Formula: C₂₃H₂₈F₂N₆O₄S

InChI: InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1

InChI key: InChIKey=OEKWJQXRCDYSHL-FNOIDJSQSA-N

SMILES: FC1=CC=C(C=C1F)C2CC2NC3=NC(=NC4=C3N=NN4C5CC(OCCO)C(O)C5O)SCCC

Synonyms:

• (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol
• (1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol
• 1,2-Cyclopentanediol, 3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-
• Ar-C 126532Xx
• Ar-C126532
• Azd 6140
• Azd6140
• Brilinta
• Brilique
• Possia
• Ticagrelor
• Triafluocyl

Ticagrelor CRS

CAS: 274693-27-5

Ticagrelor

CAS: 274693-27-5

Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure

• Formula: C₂₃H₂₈F₂N₆O₄S
• Color and Shape: White Off-White Pink Powder
• Molecular weight: 522.18608

1,2-Cyclopentanediol,3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-,(1S,2S,3R,5S)-

CAS: 274693-27-5

• Formula: C₂₃H₂₈F₂N₆O₄S
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 522.5680

Ticagrelor

CAS: 274693-27-5

Ticagrelor (AR-C 126532XX), produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor …

• Formula: C₂₃H₂₈F₂N₆O₄S
• Purity: 100%
• Color and Shape: Solid
• Molecular weight: 522.57

Ticagrelor

CAS: 274693-27-5

• Formula: C₂₃H₂₈F₂N₆O₄S
• Purity: ≥ 98.0%
• Color and Shape: White to off-white powder
• Molecular weight: 522.57

Ticagrelor

CAS: 274693-27-5

• Formula: C₂₃H₂₈F₂N₆O₄S
• Color and Shape: White To Off-White Solid
• Molecular weight: 522.57

Ticagrelor

CAS: 274693-27-5

• Formula: C₂₃H₂₈F₂N₆O₄S
• Color and Shape: White
• Molecular weight: 522.57

Ticagrelor Impurity 18

CAS: 274693-27-5

• Formula: C₇H₉Cl₂N₃O₂S
• Color and Shape: White To Off-White Solid
• Molecular weight: 270.13

Ticagrelor

CAS: 274693-27-5

Stability Hygroscopic Applications Ticagrelor, the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and …

• Formula: C₂₃H₂₈F₂N₆O₄S
• Color and Shape: White
• Molecular weight: 522.57

Ticagrelor

CAS: 274693-27-5

Reversible P2Y12 receptor antagonist; ADP-induced platelet aggregation blocker

• Formula: C₂₃H₂₈F₂N₆O₄S
• Purity: Min. 95%
• Color and Shape: White Powder
• Molecular weight: 522.57 g/mol

Ticagrelor - Bio-X ™

CAS: 274693-27-5

Ticagrelor is a P2Y12 receptor antagonist that has been shown to reduce the risk of …

• Formula: C₂₃H₂₈F₂N₆O₄S
• Purity: Min. 95%
• Color and Shape: Powder
• Molecular weight: 522.57 g/mol

ent-Ticagrelor-d7

CAS: 274693-27-5

• Formula: C₂₃H₂₁D₇F₂N₆O₄S
• Molecular weight: 260.284